168 related articles for article (PubMed ID: 15466163)
1. High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line.
Yueh MF; Kawahara M; Raucy J
Drug Metab Dispos; 2005 Jan; 33(1):38-48. PubMed ID: 15466163
[TBL] [Abstract][Full Text] [Related]
2. A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
Trubetskoy O; Marks B; Zielinski T; Yueh MF; Raucy J
AAPS J; 2005 Mar; 7(1):E6-13. PubMed ID: 16146350
[TBL] [Abstract][Full Text] [Related]
3. A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
Raucy J; Warfe L; Yueh MF; Allen SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):412-23. PubMed ID: 12235278
[TBL] [Abstract][Full Text] [Related]
4. Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes.
Yueh MF; Kawahara M; Raucy J
Toxicol In Vitro; 2005 Mar; 19(2):275-87. PubMed ID: 15649641
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products.
Raucy JL
Drug Metab Dispos; 2003 May; 31(5):533-9. PubMed ID: 12695340
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate.
Nallani SC; Glauser TA; Hariparsad N; Setchell K; Buckley DJ; Buckley AR; Desai PB
Epilepsia; 2003 Dec; 44(12):1521-8. PubMed ID: 14636322
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of luciferin-isopropyl acetal as a CYP3A4 substrate for human hepatocytes: effects of organic solvents, cytochrome P450 (P450) inhibitors, and P450 inducers.
Li AP
Drug Metab Dispos; 2009 Aug; 37(8):1598-603. PubMed ID: 19451401
[TBL] [Abstract][Full Text] [Related]
8. A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro.
Ogg MS; Williams JM; Tarbit M; Goldfarb PS; Gray TJ; Gibson GG
Xenobiotica; 1999 Mar; 29(3):269-79. PubMed ID: 10219967
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of chloroacetanilide herbicide alachlor in HepG2 cells independent of CYP3A4 and CYP3A7.
Miranda SR; Meyer SA
Food Chem Toxicol; 2007 May; 45(5):871-7. PubMed ID: 17207564
[TBL] [Abstract][Full Text] [Related]
10. 3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.
Antolino-Lobo I; Meulenbelt J; Nijmeijer SM; Maas-Bakker RF; Meijerman I; van den Berg M; van Duursen MB
Toxicol Lett; 2011 May; 203(1):82-91. PubMed ID: 21402137
[TBL] [Abstract][Full Text] [Related]
11. CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development.
Luo G; Guenthner T; Gan LS; Humphreys WG
Curr Drug Metab; 2004 Dec; 5(6):483-505. PubMed ID: 15578943
[TBL] [Abstract][Full Text] [Related]
12. Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction.
Doshi U; Li AP
J Biomol Screen; 2011 Sep; 16(8):903-9. PubMed ID: 21832258
[TBL] [Abstract][Full Text] [Related]
13. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes.
Nallani SC; Goodwin B; Buckley AR; Buckley DJ; Desai PB
Cancer Chemother Pharmacol; 2004 Sep; 54(3):219-29. PubMed ID: 15175893
[TBL] [Abstract][Full Text] [Related]
14. Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction.
Ripp SL; Mills JB; Fahmi OA; Trevena KA; Liras JL; Maurer TS; de Morais SM
Drug Metab Dispos; 2006 Oct; 34(10):1742-8. PubMed ID: 16837568
[TBL] [Abstract][Full Text] [Related]
15. Avasimibe induces CYP3A4 and multiple drug resistance protein 1 gene expression through activation of the pregnane X receptor.
Sahi J; Milad MA; Zheng X; Rose KA; Wang H; Stilgenbauer L; Gilbert D; Jolley S; Stern RH; LeCluyse EL
J Pharmacol Exp Ther; 2003 Sep; 306(3):1027-34. PubMed ID: 12766253
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
17. Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers.
El-Sankary W; Gibson GG; Ayrton A; Plant N
Drug Metab Dispos; 2001 Nov; 29(11):1499-504. PubMed ID: 11602528
[TBL] [Abstract][Full Text] [Related]
18. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor.
Casabar RC; Das PC; Dekrey GK; Gardiner CS; Cao Y; Rose RL; Wallace AD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):335-43. PubMed ID: 20361990
[TBL] [Abstract][Full Text] [Related]
19. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.
Zhou SF
Curr Drug Metab; 2008 May; 9(4):310-22. PubMed ID: 18473749
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components.
Jiang B; Cai F; Gao S; Meng L; Liang F; Dai X; Xu W; Chen W
Chem Biol Interact; 2012 Jan; 195(2):105-13. PubMed ID: 22178124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
